Related Experiment Video
Updated: Jul 20, 2026
09:43
Co-Culture and Transduction of Murine Thymocytes on Delta-Like 4-Expressing Stromal Cells to Study Oncogenes in T-Cell Leukemia
Published on: June 9, 2023
[Expression of Smad4 in leukemia cells]
Yan Zhang1, Xu Cao, Ming Jiang
1Central Laboratory, The First Affiliated Hospital, Xinjiang Medical University, Urumqi 830054, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|August 25, 2006
Summary
Loss of Smad4 protein expression is observed in many leukemia patients, particularly in acute myeloid leukemia (AML). This suggests Smad4 alterations may contribute to the development of AML.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Context:
- Transforming growth factor (TGF)-beta signaling is crucial in preventing malignant transformation.
- Smad4 is a key protein in TGF-beta signal transduction.
- Smad4 alterations are linked to various cancers.
Purpose:
- To investigate the expression and cellular location of Smad4 in leukemia blast cells.
- To explore the potential role of Smad4 in the pathogenesis of leukemia.
Summary:
- Smad4 protein was primarily found in the nucleus, with some in the cytoplasm, of leukemia blast cells.
- Smad4 expression was undetectable in 6/9 acute lymphoblastic leukemia (ALL), 7/24 acute myeloid leukemia (AML), and 1/2 chronic myeloid leukemia (CML) patients.
- Specific leukemia subtypes with undetectable Smad4 expression were detailed, including L1, L3, L2, M0, M1, M2a, M3a, M4b, M6, and CML.
Impact:
- The study indicates that Smad4 deletion or functional changes may be associated with the development of human AML.
- Findings highlight Smad4 as a potential biomarker or therapeutic target in AML research.
